These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4646161)

  • 21. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
    Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
    Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytophotometric study of cervical smears.
    Lagerlöf B; Adams LR
    Acta Cytol; 1969 Feb; 13(2):57-8. PubMed ID: 5255141
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies with cancer seeking isotopes.
    Nathanson L
    Mater Med Pol; 1971; 3(3):21-7. PubMed ID: 5162164
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the DNA level in the differential cytodiagnosis of benign and malignant stomach lesions].
    Vasilenko VKh; Matiushina ED; Rapoport SI
    Klin Med (Mosk); 1972 Dec; 50(12):17-24. PubMed ID: 4660497
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of protein tyrosine kinases in head and neck squamous cell carcinomas.
    Perrone F; Losa M; Lagonigro MS; Pilotti S
    Am J Clin Pathol; 2006 Oct; 126(4):618. PubMed ID: 17019796
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.
    Tamás L; Kraxner H; Mechtler L; Répássy G; Ribári O; Hirschberg A; Szentkúti G; Járay B; Szentirmay Z
    Anticancer Res; 2000; 20(5C):4031-7. PubMed ID: 11268497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with the cytological diagnosis of head and neck tumors].
    Bangsbo C; Sorensen H
    Nord Med; 1971 Jul; 86(27):831. PubMed ID: 5558471
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG; Schmidt A; Nehls O; Kaiser S
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis.
    Holm LE
    Laryngoscope; 1982 Sep; 92(9 Pt 1):1064-9. PubMed ID: 7121161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staging of head and neck cancer.
    Denic S
    N Engl J Med; 1995 Jun; 332(26):1789; author reply 1789-90. PubMed ID: 7619167
    [No Abstract]   [Full Text] [Related]  

  • 31. [Melting method in the detection of differences between DNA from normal and tumor tissues].
    Babaian IuS; Vardevanian PO; Garibian DV; Arutiunian SG; Kulaga LL
    Biofizika; 1984; 29(2):313-4. PubMed ID: 6722198
    [No Abstract]   [Full Text] [Related]  

  • 32. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.
    Yoo GH; Xu HJ; Brennan JA; Westra W; Hruban RH; Koch W; Benedict WF; Sidransky D
    Cancer Res; 1994 Sep; 54(17):4603-6. PubMed ID: 8062250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and experimental oncology].
    Arch Otorhinolaryngol Suppl; 1984; 2():263-72. PubMed ID: 6596921
    [No Abstract]   [Full Text] [Related]  

  • 34. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
    Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
    Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA analysis of head and neck squamous cell carcinoma by flow cytometry.
    Lampe HB
    Laryngoscope; 1993 Jun; 103(6):637-44. PubMed ID: 8099190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Flow-cytometry].
    Killmann SA
    Ugeskr Laeger; 1978 Jan; 140(4):185-6. PubMed ID: 636047
    [No Abstract]   [Full Text] [Related]  

  • 38. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry.
    Ensley JF; Maciorowski Z; Hassan M; Pietraszkiewicz H; Sakr W; Heilbrun LK
    Cytometry; 1993; 14(5):550-8. PubMed ID: 8354128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma.
    Hashimoto Y; Oga A; Okami K; Imate Y; Yamashita Y; Sasaki K
    Cytometry; 2000 Jun; 40(2):161-6. PubMed ID: 10805936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening strategies for familial paragangliomas.
    Verma S; Qureshi AA
    Clin Otolaryngol; 2007 Aug; 32(4):299-300; author reply 300-1. PubMed ID: 17651279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.